Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
J Neurol Neurosurg Psychiatry ; 92(7): 751-756, 2021 07.
Artigo em Inglês | MEDLINE | ID: mdl-33158914

RESUMO

OBJECTIVE: Single cases and small series of Guillain-Barré syndrome (GBS) have been reported during the SARS-CoV-2 outbreak worldwide. We evaluated incidence and clinical features of GBS in a cohort of patients from two regions of northern Italy with the highest number of patients with COVID-19. METHODS: GBS cases diagnosed in 12 referral hospitals from Lombardy and Veneto in March and April 2020 were retrospectively collected. As a control population, GBS diagnosed in March and April 2019 in the same hospitals were considered. RESULTS: Incidence of GBS in March and April 2020 was 0.202/100 000/month (estimated rate 2.43/100 000/year) vs 0.077/100 000/month (estimated rate 0.93/100 000/year) in the same months of 2019 with a 2.6-fold increase. Estimated incidence of GBS in COVID-19-positive patients was 47.9/100 000 and in the COVID-19-positive hospitalised patients was 236/100 000. COVID-19-positive patients with GBS, when compared with COVID-19-negative subjects, showed lower MRC sum score (26.3±18.3 vs 41.4±14.8, p=0.006), higher frequency of demyelinating subtype (76.6% vs 35.3%, p=0.011), more frequent low blood pressure (50% vs 11.8%, p=0.017) and higher rate of admission to intensive care unit (66.6% vs 17.6%, p=0.002). CONCLUSIONS: This study shows an increased incidence of GBS during the COVID-19 outbreak in northern Italy, supporting a pathogenic link. COVID-19-associated GBS is predominantly demyelinating and seems to be more severe than non-COVID-19 GBS, although it is likely that in some patients the systemic impairment due to COVID-19 might have contributed to the severity of the whole clinical picture.


Assuntos
COVID-19/complicações , Síndrome de Guillain-Barré/epidemiologia , Adulto , Idoso , COVID-19/diagnóstico , COVID-19/terapia , Feminino , Síndrome de Guillain-Barré/diagnóstico , Síndrome de Guillain-Barré/terapia , Hospitalização , Humanos , Incidência , Itália , Masculino , Pessoa de Meia-Idade , Encaminhamento e Consulta , Estudos Retrospectivos
2.
Neurologist ; 18(6): 378-84, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23114670

RESUMO

BACKGROUND: Paraproteinemic neuropathy (PPN) is often under-diagnosed because of its clinical and electrophysiological variability. Progression of neuropathy is considered an alarm bell for possible malignant conversion of underlying monoclonal gammopathy (MG). OBJECTIVE: To report clinical presentation, course, and evolution in a group of patients with PPN in order to identify findings useful for achieving the diagnosis, suspecting progression, and recognizing the underlying hematological conditions. PATIENTS AND METHODS: Thirty-nine patients with PPN underwent clinical examination, electrodiagnostic studies, cerebrospinal fluid analysis, and laboratory tests. These parameters were compared between the different peak groups. RESULTS: IgM MG was found in 51.4%, IgG MG in 33.3%, and IgA MG in 10.3% of our cohort. PPN appeared as mainly sensory, demyelinating, mildly progressive neuropathy, regardless of the type of peak or light chain. However, axonal findings were present in many IgG patients and in part of the IgM patients and a small number of the IgG patients may have presented with motor symptoms at the onset. The IgM patients had a significant tendency toward clinical worsening and IgG subjects had a more elevated rate of malignancy. IgA-related neuropathies were rare, heterogenous, and with a high tendency to evolution and malignancy. CONCLUSIONS: Most of PPN often present a relatively monomorphic clinical picture but they can be clinically heterogenous and must be suspected even if sensory impairment and demyelination are not the dominant features. Tendency to malignancy seems globally elevated and needs intensive follow-up. Diagnostic approach to patients presenting with peripheral neuropathy should always include the typing of monoclonal immunoglobulins in serum and urine. In contrast, patients presenting with MG should be submitted to nerve conduction study/electroneurography and neurological evaluation.


Assuntos
Paraproteinemias/diagnóstico , Doenças do Sistema Nervoso Periférico/etiologia , Distribuição por Idade , Idade de Início , Idoso , Idoso de 80 Anos ou mais , Axônios/imunologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Condução Nervosa , Paraproteinemias/complicações , Paraproteinemias/imunologia , Doenças do Sistema Nervoso Periférico/epidemiologia
4.
Neurologist ; 16(6): 340-52, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21150381

RESUMO

UNLABELLED: The limb-girdle muscular dystrophies are a genetically and clinically heterogeneous group of diseases. Most of these proteinopathies show wide inter- and intrafamilial phenotypic heterogeneity, so that limb-girdle involvement may be often considered as one of the possible clinical expressions of a determined protein defect. REVIEW SUMMARY: This review reports an updated and comprehensive classification of these proteinopathies according to protein defect and transmission modality and focuses on the main associated clinical pictures. CONCLUSIONS: An accurate diagnosis is often difficult because of the clinical and genetic variability characterizing this group of muscle diseases. Appropriate diagnostic approaches are essential to achieve the correct diagnosis.


Assuntos
Proteínas Musculares/genética , Proteínas Musculares/metabolismo , Distrofia Muscular do Cíngulo dos Membros/fisiopatologia , Conectina , Proteínas do Citoesqueleto/genética , Humanos , Proteínas dos Microfilamentos , Biologia Molecular , Distrofia Muscular do Cíngulo dos Membros/classificação , Distrofia Muscular do Cíngulo dos Membros/genética , Distrofia Muscular do Cíngulo dos Membros/patologia , Mutação , Fenótipo
5.
J Neuroimmunol ; 225(1-2): 184-9, 2010 Aug 25.
Artigo em Inglês | MEDLINE | ID: mdl-20542337

RESUMO

To investigate molecular mechanisms of peripheral nerve vasculitis, gene expression patterns in archived frozen sural nerve biopsies from patients with vasculitic neuropathy were compared to control nerves by DNA microarray technology. There was a striking upregulation of mRNA of genes involved in immune system processes. Of special interest was the activation of immunoglobulin genes, such as IGLJ3, IGHG3, IGKC, and IGL, and of several chemokines, such as CXCL9 or CCR2. Genes involved in vascular proliferation or remodelling such as CXC31 and AIF were also upregulated. Among the downregulated genes were the Krüppel-Like Transcription Factors KLF2, KLF4 and the nuclear orphan receptor NR4A1 genes known to be involved in endothelial cell activation. Thus, this gene expression profile analysis revealed that in peripheral nerve vasculitis a prominent activation of immune response related genes as well as genes involved in vascular proliferation is taken place, while genes inhibiting endothelial cell activation are down regulated. These data point to interesting mechanistic clues to the molecular pathogenesis of vasculitic neuropathies.


Assuntos
Perfilação da Expressão Gênica/métodos , Regulação da Expressão Gênica/fisiologia , Doenças do Sistema Nervoso Periférico/patologia , Nervo Sural/metabolismo , Vasculite/patologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia/métodos , Pré-Escolar , Feminino , Humanos , Fator 4 Semelhante a Kruppel , Fatores de Transcrição Kruppel-Like/genética , Fatores de Transcrição Kruppel-Like/metabolismo , Masculino , Membro 1 do Grupo A da Subfamília 4 de Receptores Nucleares/genética , Membro 1 do Grupo A da Subfamília 4 de Receptores Nucleares/metabolismo , Doenças do Sistema Nervoso Periférico/complicações , Doenças do Sistema Nervoso Periférico/genética , Doenças do Sistema Nervoso Periférico/metabolismo , Nervo Sural/imunologia , Vasculite/complicações , Vasculite/genética , Vasculite/metabolismo
6.
J Neurol Sci ; 284(1-2): 179-81, 2009 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-19375087

RESUMO

Hypocomplementemic urticarial vasculitis (HUV) is a rare form of cutaneous small-vessel vasculitis characterized by recurrent episodes of urticaria and painful, tender, burning or itchy skin lesions, often associated with extracutaneous involvement but usually with no significant peripheral nerve damage. We describe a patient with an HUV of undetermined cause that developed a progressive multifocal sensory neuropathy whose symptoms were temporarily relieved by intravenous immunoglobulin treatment. Sural nerve biopsy showed asymmetrical multifocal nerve fiber loss and axon degeneration in nerve fascicles, a picture suggestive of ischemic damage as a likely result of a vasculitic process. We point out that an axonal neuropathy may complicate idiopathic HUV and suggest looking for peripheral nerve involvement in HUV patients.


Assuntos
Proteínas do Sistema Complemento/deficiência , Nervos Periféricos/irrigação sanguínea , Doenças do Sistema Nervoso Periférico/etiologia , Urticária/etiologia , Vasculite Leucocitoclástica Cutânea/complicações , Degeneração Walleriana/etiologia , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/uso terapêutico , Axônios/patologia , Azatioprina/administração & dosagem , Azatioprina/uso terapêutico , Biópsia , Quimioterapia Combinada , Feminino , Humanos , Imunoglobulinas Intravenosas/uso terapêutico , Imunossupressores/administração & dosagem , Imunossupressores/uso terapêutico , Metilprednisolona/administração & dosagem , Metilprednisolona/uso terapêutico , Pessoa de Meia-Idade , Nervos Periféricos/patologia , Doenças do Sistema Nervoso Periférico/patologia , Nervo Sural/patologia , Urticária/tratamento farmacológico , Vasculite Leucocitoclástica Cutânea/tratamento farmacológico , Vasculite Leucocitoclástica Cutânea/patologia
7.
Muscle Nerve ; 38(4): 1272-9, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18816612

RESUMO

Allograft inflammatory factor-1 (AIF-1) is a cytokine that plays a major role in the immune response and proliferative vasculopathy that occur during chronic allograft rejection. The purpose of this study was to characterize the cellular expression pattern and pathogenetic role of AIF-1 in nerve biopsies from patients with vasculitic neuropathy. We performed immunohistochemistry in human nerve biopsies of 10 patients with vasculitic neuropathies (VASs), 6 with chronic inflammatory demyelinating polyneuropathies (CIDPs), 5 with noninflammatory axonal neuropathies (NIANs), and 3 control nerves (CNs). In the CIDP and VAS nerves, AIF-1 expression was higher than in CN and NIAN nerves (P < 0.05). AIF-1 was increased in the arterial walls of VAS compared with CIDP nerves (P < 0.05). Vascular smooth muscle cells in vasculitic nerve express AIF-1 at a higher level compared with CIDP and NIAN. AIF-1 plays a role in inflammatory nerve disease and vascular smooth muscle cell proliferation and may be a new molecular target for treatment.


Assuntos
Proteínas de Ligação a DNA/metabolismo , Nervos Periféricos/metabolismo , Doenças do Sistema Nervoso Periférico/metabolismo , Polirradiculoneuropatia Desmielinizante Inflamatória Crônica/metabolismo , Vasculite/metabolismo , Adulto , Idoso , Artérias/metabolismo , Artérias/patologia , Artérias/fisiopatologia , Biomarcadores/análise , Biomarcadores/metabolismo , Biópsia , Proteínas de Ligação ao Cálcio , Quimiotaxia de Leucócito/imunologia , Proteínas de Ligação a DNA/análise , Feminino , Humanos , Imuno-Histoquímica , Masculino , Proteínas dos Microfilamentos , Pessoa de Meia-Idade , Músculo Liso Vascular/metabolismo , Músculo Liso Vascular/patologia , Músculo Liso Vascular/fisiopatologia , Nervos Periféricos/patologia , Nervos Periféricos/fisiopatologia , Doenças do Sistema Nervoso Periférico/patologia , Doenças do Sistema Nervoso Periférico/fisiopatologia , Polirradiculoneuropatia Desmielinizante Inflamatória Crônica/patologia , Polirradiculoneuropatia Desmielinizante Inflamatória Crônica/fisiopatologia , Nervo Sural/metabolismo , Nervo Sural/patologia , Nervo Sural/fisiopatologia , Regulação para Cima/fisiologia , Vasculite/patologia , Vasculite/fisiopatologia
8.
Brain ; 131(Pt 7): 1912-25, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18524793

RESUMO

Small fibre neuropathy (SFN), a condition dominated by neuropathic pain, is frequently encountered in clinical practise either as prevalent manifestation of more diffuse neuropathy or distinct nosologic entity. Aetiology of SFN includes pre-diabetes status and immune-mediated diseases, though it remains frequently unknown. Due to their physiologic characteristics, small nerve fibres cannot be investigated by routine electrophysiological tests, making the diagnosis particularly difficult. Quantitative sensory testing (QST) to assess the psychophysical thresholds for cold and warm sensations and skin biopsy with quantification of somatic intraepidermal nerve fibres (IENF) have been used to determine the damage to small nerve fibres. Nevertheless, the diagnostic criteria for SFN have not been defined yet and a 'gold standard' for clinical practise and research is not available. We screened 486 patients referred to our institutions and collected 124 patients with sensory neuropathy. Among them, we identified 67 patients with pure SFN using a new diagnostic 'gold standard', based on the presence of at least two abnormal results at clinical, QST and skin biopsy examination. The diagnosis of SFN was achieved by abnormal clinical and skin biopsy findings in 43.3% of patients, abnormal skin biopsy and QST findings in 37.3% of patients, abnormal clinical and QST findings in 11.9% of patients, whereas 7.5% patients had abnormal results at all the examinations. Skin biopsy showed a diagnostic efficiency of 88.4%, clinical examination of 54.6% and QST of 46.9%. Receiver operating characteristic curve analysis confirmed the significantly higher performance of skin biopsy comparing with QST. However, we found a significant inverse correlation between IENF density and both cold and warm thresholds at the leg. Clinical examination revealed pinprick and thermal hypoesthesia in about 50% patients, and signs of peripheral vascular autonomic dysfunction in about 70% of patients. Spontaneous pain dominated the clinical picture in most SFN patients. Neuropathic pain intensity was more severe in patients with SFN than in patients with large or mixed fibre neuropathy, but there was no significant correlation with IENF density. The aetiology of SFN was initially unknown in 41.8% of patients and at 2-year follow-up a potential cause could be determined in 25% of them. Over the same period, 13% of SFN patients showed the involvement of large nerve fibres, whereas in 45.6% of them the clinical picture did not change. Spontaneous remission of neuropathic pain occurred in 10.9% of SFN patients, while it worsened in 30.4% of them.


Assuntos
Doenças do Sistema Nervoso Periférico/diagnóstico , Transtornos de Sensação/diagnóstico , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia , Temperatura Baixa , Técnicas de Diagnóstico Neurológico , Feminino , Temperatura Alta , Humanos , Fluxometria por Laser-Doppler/métodos , Masculino , Pessoa de Meia-Idade , Fibras Nervosas/patologia , Condução Nervosa , Dor/etiologia , Medição da Dor/métodos , Doenças do Sistema Nervoso Periférico/etiologia , Doenças do Sistema Nervoso Periférico/patologia , Estudos Retrospectivos , Transtornos de Sensação/etiologia , Transtornos de Sensação/patologia , Limiar Sensorial , Pele/inervação , Pele/patologia , Sensação Térmica
9.
Clin Toxicol (Phila) ; 46(4): 314-6, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18363127

RESUMO

BACKGROUND: Disulfiram may cause a peripheral neuropathy that is considered dose- and duration-of-exposure-related. Axonal degeneration has been described as a pathological hallmark of disulfiram toxicity, but experiments have reported a primary toxic effect of the molecule on Schwann cells and myelin. CASE REPORTS: Case 1: At the end of two months of treatment with disulfiram 250 mg/day, a 31-year-old woman complained of weakness in distal segments of the lower limbs associated with burning dysesthesias, numbness and pain in the soles of the feet and the legs below the knees; bilateral walking steppage, reduction in foot strength, absence of ankle jerk and knee tendon reflexes, and tactile stocking pin-pick and vibratory sensory impairment in the lower limbs below the knee. Disulfiram was discontinued and she recovered partially over three months. Case 2: After one month of treatment with disulfiram 1600 mg/day, a 27-year-old man reported walking impairment, distal lower limb weakness and paresthesias. He had unsteady gait with bilateral steppage and foot drop, absence of ankle jerks and overall sensation impairment below the knee. Disulfiram was discontinued and nine months later there was almost complete recovery of motor deficits, only minor motor weakness in distal leg muscles, and no dysesthesia, sensation deficits or areflexia. In both of them clinical and neurophysiological patterns were indicative of a distal axonopathy. DISCUSSION The mechanisms by which disulfiram cause injury in human nerves are unclear, though may involve carbon disulfide. The discrepancy between experimental and clinical observations is still unexplained. CONCLUSION: We report two cases of disulfiram axonal toxicity and the partial response following discontinuation of the drug.


Assuntos
Dissuasores de Álcool/efeitos adversos , Axônios/efeitos dos fármacos , Dissulfiram/efeitos adversos , Nervos Periféricos/efeitos dos fármacos , Doenças do Sistema Nervoso Periférico/induzido quimicamente , Adulto , Axônios/patologia , Feminino , Humanos , Masculino , Nervos Periféricos/patologia , Doenças do Sistema Nervoso Periférico/patologia , Doenças do Sistema Nervoso Periférico/fisiopatologia , Recuperação de Função Fisiológica , Suspensão de Tratamento
10.
J Neurol Sci ; 263(1-2): 40-3, 2007 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-17612569

RESUMO

Bortezomib, a proteasome inhibitor used in the treatment of multiple myeloma, is known to induce an axonal, dose-dependent neuropathy clinically characterized by pain, paresthesias, burning dysesthesias and numbness. In this study, we describe a patient treated with high-dose bortezomib whose main clinical feature was severe sensory ataxia. Electrodiagnostic studies showed, other than axonal changes, myelin involvement.


Assuntos
Ataxia/tratamento farmacológico , Ataxia/patologia , Ácidos Borônicos/uso terapêutico , Bainha de Mielina/fisiologia , Inibidores de Proteases/uso terapêutico , Pirazinas/uso terapêutico , Idoso , Ataxia/fisiopatologia , Bortezomib , Relação Dose-Resposta a Droga , Humanos , Masculino , Bainha de Mielina/efeitos dos fármacos , Condução Nervosa/efeitos dos fármacos , Condução Nervosa/fisiologia , Tempo de Reação/efeitos dos fármacos , Tempo de Reação/fisiologia
11.
Biosci Rep ; 27(1-3): 31-7, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17484046

RESUMO

Mitochondrial diseases are a group of disorders due to a mitochondrial respiratory chain deficiency. They may depend on mitochondrial genome (mtDNA-related disorders) as well as on a nuclear genome defect (nDNA-related disorders). mtDNA-related disorders encompass an increasing number of clinical pictures associated with more than 250 different provisional or confirmed pathogenic changes in mtDNA. Although some clinical syndromes are nosologically defined, most of the cases present with polymorphous phenotypes ranging from pure myopathy to multi-system involvement. Complexity of mitochondrial genetics is in part responsible for the extreme clinical intra- and inter-familial heterogeneity of this group of diseases. In this review, we briefly report an updated classification and overview the main clinical pictures of this class of diseases.


Assuntos
DNA Mitocondrial/genética , Doenças Mitocondriais/genética , Deleção de Genes , Duplicação Gênica , Genes Mitocondriais/genética , Humanos , Doenças Mitocondriais/classificação , Doenças Mitocondriais/patologia , Proteínas Mitocondriais/genética , Mutação , Mutação Puntual
13.
Arch Neurol ; 60(12): 1740-4, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14676049

RESUMO

BACKGROUND: Alteration of the amyloid precursor protein (APP) forms ratio has been described in the platelets of patients with dementia of Alzheimer type (DAT) and in a subset of subjects with mild cognitive impairment (MCI). OBJECTIVE: To evaluate the potential role of the platelet APP forms ratio in predicting progression from MCI to DAT. DESIGN: Thirty subjects with MCI underwent a clinical and neuropsychological examination and a determination of the platelet APP forms ratio. Subjects were followed up periodically for 2 years, and the progression to dementia was evaluated. SETTING: Community population-based sample of patients admitted for memory complaints. RESULTS: Patients who progressed to DAT at the 2-year follow-up (n = 12) showed a significant decrease of baseline platelet APP forms ratio values (mean +/- SD, 0.36 +/- 0.28) compared with stable MCI subjects (mean +/- SD, 0.73 +/- 0.32) (P<.01) and patients who developed other types of dementia (mean +/- SD, 0.83 +/- 0.27) (P =.03). By fixing a cutoff score of 0.6, 10 (83%) of the 12 DAT patients showed baseline values below the cutoff, whereas 10 (71%) of 14 subjects who either developed non-Alzheimer-type dementia or maintained cognitive functions had values in the normal range. CONCLUSION: Mild cognitive impairment is a major risk factor for DAT, and Alzheimer disease-related pathological changes can be identified in patients converting to DAT within a 2-year follow-up.


Assuntos
Doença de Alzheimer/etiologia , Precursor de Proteína beta-Amiloide/sangue , Plaquetas/metabolismo , Transtornos Cognitivos/sangue , Transtornos Cognitivos/complicações , Idoso , Doença de Alzheimer/diagnóstico , Transtornos Cognitivos/diagnóstico , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Prognóstico , Fatores de Risco
14.
Neurobiol Dis ; 13(1): 15-21, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12758063

RESUMO

CST3 is the coding gene for cystatin C (CysC). CST3 B/B homozygosity is associated with an increased risk of developing Alzheimer disease. We performed CysC analysis on human primary skin fibroblasts obtained from donors carrying A/A, A/B, and B/B CST3. Pulse-chase experiments demonstrated that the release of the B variant of CysC has a different temporal pattern compared to that of the A one. Fibroblasts B/B homozygous displayed a reduced secretion of CysC due to a less efficient cleavage of the signal peptide, as suggested by high-resolution Western blot analysis and by in vitro assay. In the brain, the reduced level of CysC may represent the molecular factor responsible for the increased risk of Alzheimer disease.


Assuntos
Doença de Alzheimer/genética , Cistatinas/genética , Cistatinas/metabolismo , Idoso , Western Blotting , Células Cultivadas , Cistatina C , Feminino , Fibroblastos/citologia , Fibroblastos/metabolismo , Predisposição Genética para Doença , Haplótipos , Homozigoto , Humanos , Masculino , Pessoa de Meia-Idade , Sinais Direcionadores de Proteínas/fisiologia , Pele/citologia
15.
Arq. Centro Estud. Curso Odontol ; 27(1/2): 9-15, jan.-dez. 1990. tab
Artigo em Português | LILACS, BBO - odontologia (Brasil) | ID: lil-119991

RESUMO

A presença de fungos e bactérias foi estudada em 26 pacientes portadores de estomatite e os resultados comparados com os obtidos de mucosa normal de pacientes desdentados, usuários ou näo de prótese total. O uso de prótese provocou aumento na quantidade de fungos, havendo correlaçäo com a severidade da estomatite. Em todos os grupos estudados, predominaram cocos e bacilos Gram positivos, sendo que na presença de estomatite houve aumento de filamentosos Gram positivos e de cocos e bacilos Gram negativos. Estes resultados sugerem que, além dos fungos, a modificaçäo da microbiota bacteriana pode ser relevante no desenvolvimento da estomatite provocada por prótese total superior


Assuntos
Humanos , Adulto , Pessoa de Meia-Idade , Candidíase Bucal , Estomatite sob Prótese/microbiologia , Estomatite/microbiologia , Leveduras
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA